BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18765955)

  • 1. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Shi X; Zou D; Li Z
    Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
    Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can wire-guided cannulation reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis? A meta-analysis of randomized controlled trials.
    Shao LM; Chen QY; Chen MY; Cai JT
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1710-5. PubMed ID: 20136957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of prophylactic allopurinol use in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Zheng M; Chen Y; Bai J; Xin Y; Pan X; Zhao L
    Pancreas; 2008 Oct; 37(3):247-53. PubMed ID: 18815544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis.
    Bai Y; Gao J; Zhang W; Zou D; Li Z
    Aliment Pharmacol Ther; 2008 Sep; 28(5):557-64. PubMed ID: 18714440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials.
    Shi N; Deng L; Altaf K; Huang W; Xue P; Xia Q
    Turk J Gastroenterol; 2015 May; 26(3):236-40. PubMed ID: 26006198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic antibiotics cannot prevent endoscopic retrograde cholangiopancreatography-induced cholangitis: a meta-analysis.
    Bai Y; Gao F; Gao J; Zou DW; Li ZS
    Pancreas; 2009 Mar; 38(2):126-30. PubMed ID: 19238021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.
    Dai HF; Wang XW; Zhao K
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):11-6. PubMed ID: 19208508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
    Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
    Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: octreotide prevents post-ERCP pancreatitis, but only at sufficient doses.
    Zhang Y; Chen QB; Gao ZY; Xie WF
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1155-64. PubMed ID: 19302265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: Nitroglycerin for prevention of post-ERCP pancreatitis.
    Bang UC; Nøjgaard C; Andersen PK; Matzen P
    Aliment Pharmacol Ther; 2009 May; 29(10):1078-85. PubMed ID: 19236312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
    Chen S; Shi H; Zou X; Luo H
    Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D; Kiss A; Wetz RV; Sottile VM
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
    Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
    Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis?: A meta-analysis of randomized controlled trials.
    Cennamo V; Fuccio L; Zagari RM; Eusebi LH; Ceroni L; Laterza L; Fabbri C; Bazzoli F
    Am J Gastroenterol; 2009 Sep; 104(9):2343-50. PubMed ID: 19532133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography.
    Brand M; Bizos D; O'Farrell P
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007345. PubMed ID: 20927758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.